HMGB1 and Sepsis: Several studies have shown that therapeutic intervention aimed at targeting inflammation induced by HMGB1 could improve survival in animal models (130, 131); however, no study has specifically addressed the potential interest of such an approach in reducing kidney inflammation and the incidence of AKI during sepsis.